Cancer: Rising Incidence Among Younger Adults. Cancer rates among adolescents and adults under 50 are rising globally, but ...

Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea", or the "Company"), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...

Researchers don’t know what might account for the link between ultraprocessed foods and colorectal cancer risk. But they do ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...

Worldwide, colorectal cancer is the second leading cause of cancer-related mortality and the third most common cancer, with incidence rates increasing among individuals younger than 50 years.1 ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

A new study found that women who eat a lot of ultra-processed foods were 1.5 times more likely to develop pre-cancerous polyps before the age of 50, compared to those with healthier diets.

Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...

Scientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From ...

The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...